To explore the potential functional roles of Api in the progression of bacterial infection, AM was orally administered (10 mg kg−1) three times at ‐27, ‐15, and ‐3 h and then subjected to CLP surgery. The gene discussed is SERPINF2; the disease is bacterial infectious disease.